Xing Shen - Lotus Pharmaceuticals Insider

LTUS -- USA Stock  

USD 0.015  0.00004  0.27%

VP of Corporate Devel.

Dr. Xing Shen, Ph.D., is Vice President Corporationrationrate Development of Lotus Pharmaceuticals, Inc. He was with the Company since July 2009. From July 2006 through May 2009, Mr. Shen was an associate equity analyst for RBC Capital Markets, where he cocovered approximately 30 companies in the biotech industry. Mr. Shen received a Masters of Business Administration in 2006 and a Doctorate in Molecular Cancer Biology in 2000 from Duke University. Mr. Shen received a MS in plant molecular biology from Peking University in 1995 and a BS in Virology from Wuhan University in 1992
Age: 39  VP Since 2010  CFA    
86 10 6389 9868
Shen has received Series 7, 63, 86 and 87 licenses from Finra and is a Chartered Financial Analyst level one candidate.

Management Efficiency

The company has return on total asset (ROA) of 4.56 % which means that it generated profit of $4.56 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 1.82 % meaning that it created $1.82 on every $100 dollars invested by stockholders.
The company currently holds 6.18 M in liabilities with Debt to Equity (D/E) ratio of 6.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Lotus Pharmaceuticals has Current Ratio of 0.52 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Entity Summary

Lotus Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceuticals in the Peoples Republic of China. Lotus Pharmaceuticals, Inc. is based in Beijing, the Peoples Republic of China. Lotus Pharmaceuticals operates under Drug Manufacturers - Specialty Generic classification in USA and traded on OTC Market. It employs 233 people.Lotus Pharmaceuticals (LTUS) is traded on OTC Market in USA. It is located in 16 Cheng Zhuang Road and employs 233 people.

Lotus Pharmaceuticals Leadership Team

Li Zhaohui, Director
Fan Lijun, Director
Xing Shen, VP, CFA
Yan Zeng, CFO, CPA
Lu Jun, Director
Zhongyi Liu, Chairman

Stock Performance Indicators

Did you try this?

Run Idea Analyzer Now

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Idea Analyzer

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see also Stocks Correlation. Please also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.